BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 9704739)

  • 21. Racial differences in the survival of childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
    Pollock BH; DeBaun MR; Camitta BM; Shuster JJ; Ravindranath Y; Pullen DJ; Land VJ; Mahoney DH; Lauer SJ; Murphy SB
    J Clin Oncol; 2000 Feb; 18(4):813-23. PubMed ID: 10673523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic implication of DNA contents on long-term outcome of childhood acute lymphoblastic leukemia].
    Tsurusawa M; Katano N; Aoyama M; Fujimoto T; Nishikawa K; Hatae Y; Miyake M; Kawakami K; Furuyama T; Iwai A; Horikoshi Y
    Rinsho Ketsueki; 1997 Jul; 38(7):561-5. PubMed ID: 9267157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies.
    Vaitkevičienė G; Forestier E; Hellebostad M; Heyman M; Jonsson OG; Lähteenmäki PM; Rosthoej S; Söderhäll S; Schmiegelow K;
    Eur J Haematol; 2011 Jan; 86(1):38-46. PubMed ID: 21077959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis Of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE).
    Donadieu J; Auclerc MF; Baruchel A; Perel Y; Bordigoni P; Landman-Parker J; Leblanc T; Cornu G; Sommelet D; Leverger G; Schaison G; Hill C;
    Br J Cancer; 2000 Dec; 83(12):1617-22. PubMed ID: 11104555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
    Cascavilla N; Musto P; D'Arena G; Ladogana S; Matera R; Carotenuto M
    Haematologica; 1997; 82(1):31-7. PubMed ID: 9107079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: a Childrens Cancer Group report.
    Gilchrist GS; Tubergen DG; Sather HN; Coccia PF; O'Brien RT; Waskerwitz MJ; Hammond GD
    J Clin Oncol; 1994 Dec; 12(12):2594-600. PubMed ID: 7989934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group.
    Salzer WL; Devidas M; Carroll WL; Winick N; Pullen J; Hunger SP; Camitta BA
    Leukemia; 2010 Feb; 24(2):355-70. PubMed ID: 20016527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
    Chessells JM; Richards SM; Bailey CC; Lilleyman JS; Eden OB
    Br J Haematol; 1995 Feb; 89(2):364-72. PubMed ID: 7873387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
    Ravindranath Y; Chang M; Steuber CP; Becton D; Dahl G; Civin C; Camitta B; Carroll A; Raimondi SC; Weinstein HJ;
    Leukemia; 2005 Dec; 19(12):2101-16. PubMed ID: 16136167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
    Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Berlin-Frankfurt-Münster Relapse Study Group.
    Bührer C; Hartmann R; Fengler R; Rath B; Schrappe M; Janka-Schaub G; Henze G
    J Clin Oncol; 1996 Oct; 14(10):2812-7. PubMed ID: 8874343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
    Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
    Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative.
    Pui CH; Raimondi SC; Hancock ML; Rivera GK; Ribeiro RC; Mahmoud HH; Sandlund JT; Crist WM; Behm FG
    J Clin Oncol; 1994 Dec; 12(12):2601-6. PubMed ID: 7989935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].
    Xu XJ; Tang YM; Song H; Shi SW; Yang SL; Shen HQ; Wei J; Xu WQ; Pan BH; Zhao FY
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):180-4. PubMed ID: 20426951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Land VJ; Shuster JJ; Crist WM; Ravindranath Y; Harris MB; Krance RA; Pinkel D; Pullen DJ
    J Clin Oncol; 1994 Sep; 12(9):1939-45. PubMed ID: 8083715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
    Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
    J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ratio of absolute lymphocyte count at interim of therapy to absolute lymphocyte count at diagnosis predicts survival in childhood B-lineage acute lymphoblastic leukemia.
    Cheng Y; Luo Z; Yang S; Jia M; Zhao H; Xu W; Tang Y
    Leuk Res; 2015 Feb; 39(2):144-50. PubMed ID: 25542697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic factors for childhood acute non-mature B-lymphoblastic leukemia].
    Jiang H; Gu LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Xu C; Dong L; Zhou M
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):290-4. PubMed ID: 18554450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Crist W; Boyett J; Jackson J; Vietti T; Borowitz M; Chauvenet A; Winick N; Ragab A; Mahoney D; Head D
    Blood; 1989 Sep; 74(4):1252-9. PubMed ID: 2669998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.